Vice President, General Manager & Campus Lead, Devens

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The General Manager, Devens is the senior leader accountable for the end-to-end performance, compliance, and strategic direction of BMS’s large-scale commercial biologics Global Business Unit (GBU) operations at Devens, and serves as the Campus Lead for the full Devens site, spanning both the GBU Biologics organization and the Cell Therapy business unit.

This role oversees all GBU Biologics site operations at Devens – from cell culture and manufacturing sciences & technology (MS&T) to large-scale commercial drug substance production – with full accountability for talent development, safety, quality, regulatory compliance, supply reliability, and cost management across the Biologics organization.

As Campus Lead, the General Manager also owns end-to-end site services and shared infrastructure – Site Engineering, Environmental Health & Safety, Security, and Facilities – that support both the GBU Biologics and Cell Therapy business units operating on the Devens campus, ensuring both organizations have the capacity, capabilities, and infrastructure to deliver on their respective missions.

A defining focus of this role over the next several years is leading the transformation and integration of the GBU Biologics and Cell Therapy business units at Devens – building a single, unified campus operating model, governance structure, and culture that harmonizes site services, talent, and ways of working across both modalities. This includes championing innovative, digitally enabled and AI-driven transformation – advanced analytics, automation, digital twins, and other Industry 4.0 capabilities – to reimagine site processes, accelerate integration, and establish Devens as a “smart campus” that delivers sustainable competitive advantage.

The General Manager also serves as the primary representative of the Devens campus both within the global manufacturing network (driving adoption of world-class standards and sharing best practices across BMS’s network of manufacturing sites) and externally (engaging with regulatory authorities, government officials, industry partners, and the local community to uphold the Company’s reputation and advance strategic initiatives).

This position is pivotal in ensuring that the Devens campus remains a world-class, innovative biologics and cell therapy manufacturing hub that reliably delivers life‑saving medicines to patients while successfully transforming into a single, integrated, future‑ready campus.

In this role, the General Manager will provide strategic, technical, and operational leadership across a broad range of functional domains and both business units  responsibilities include:

• Strategic & Enterprise Leadership:
  Develop and execute Devens’ long-range strategy in alignment with BMS’s global manufacturing network, GBU pipeline plans, and Cell Therapy growth objectives. Ensure the site’s capabilities evolve in step with enterprise needs, including readiness for new biologics modalities and Cell Therapy platform expansion. Represent Devens in Product Development and Supply (PDS) and Cell Therapy governance forums, and in enterprise-wide manufacturing network forums (e.g., Factory Level…